BEAM Q1 2022 Earnings — Beam Therapeutics Inc. Revenue & Financial Results | Market Cap Arena

BEAMBeam Therapeutics Inc.

$3B

Q1 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$8M+140433.3% YoY

Gross Profit

-$57M-675.7% margin

Operating Income

-$76M-904.0% margin

Net Income

-$69M-820.8% margin

EPS (Diluted)

$-0.80

QoQ Revenue Growth

-83.5%

Cash Flow

Operating Cash Flow

$218M

Free Cash Flow

$211M

Stock-Based Comp.

$18M

Balance Sheet

Total Assets

$1.5B

Total Liabilities

$624M

Stockholders' Equity

$829M

Cash & Equivalents

$297M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8M	$6,000	+140433.3%
Gross Profit	-$57M	-$190M	+70.0%
Operating Income	-$76M	-$200M	+62.0%
Net Income	-$69M	-$202M	+65.7%